-
1.
公开(公告)号:US20230203005A1
公开(公告)日:2023-06-29
申请号:US18117847
申请日:2023-03-06
申请人: UNIVERSITE PARIS-SACLAY , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , INSTITUT GUSTAVE-ROUSSY , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人: Mouad ALAMI , Olivier PROVOT , Abdallah HAMZE , Ilhem KHELIFI , Timothée NARET , Sébastien APCHER , Romain DARRIGRAND
IPC分类号: C07D401/12 , A61P35/00 , C07D403/12
CPC分类号: C07D401/12 , A61P35/00 , C07D403/12
摘要: The present invention relates to the Compound of following formula (I):
or a pharmaceutically acceptable salt thereof.
The present invention also relates to a pharmaceutical composition containing such a compound and a method for preparing such a compound.-
2.
公开(公告)号:US20210230140A1
公开(公告)日:2021-07-29
申请号:US17050772
申请日:2019-04-26
申请人: UNIVERSITE PARIS-SACLAY , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , INSTITUT GUSTAVE-ROUSSY , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人: Mouad ALAMI , Olivier PROVOT , Abdallah HAMZE , Ilhem KHELIFI , Timothée NARET , Sébastien APCHER , Romain DARRIGRAND
IPC分类号: C07D401/12 , A61P35/00 , C07D403/12
摘要: The present invention relates to the Compound of following formula (I): or a pharmaceutically acceptable salt thereof.
The present invention also relates to a pharmaceutical composition containing such a compound and a method for preparing such a compound.
-